Alkermes Plc
Change company Symbol lookup
Select an option...
ALKS Alkermes Plc
CPTNW Cepton Equity Warrant Exp 10th Feb 2027 *W EXP 02/10/2027
APPF Appfolio Inc
FMN Federated Hermes Premier Municipal Inc
USCTU TKB Critical Technologies 1
SIEGY Siemens AG
FDBC Fidelity D&D Bancorp Inc
$BUKCHET Bloomberg Coffee Subindex Euro
BMY Bristol-Myers Squibb Co
MLGO MicroAlgo Inc
Go

Health Care : Biotechnology | Small Cap Growth
Based in Ireland
Company profile

Alkermes Public Limited Company is an integrated biopharmaceutical company. It is engaged in researching, developing and commercializing pharmaceutical products that are designed to address unmet medical needs of patients in the fields of neuroscience and oncology. Its portfolio of commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Its products include ARISTADA, ARISTADA INITIO, LYBALVI and VIVITROL. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder. VIVITROL is a non-narcotic, injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.

Closing Price
$27.10
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Below Average)
Volume:
978,528

10-day average volume:
1,145,105
978,528

Dow's 100-point Jump Highlighted By Gains In Merck, Johnson & Johnson Stocks

2:40 pm ET November 14, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is trading up Monday afternoon with shares of Merck and Johnson & Johnson delivering strong returns for the index. The Dow was most recently trading 101 points (0.3%) higher, as shares of Merck (MRK) and Johnson & Johnson (JNJ) are contributing to the blue-chip gauge's intraday rally. Merck's shares are up $3.32 (3.4%) while those of Johnson & Johnson have climbed $3.78, or 2.2%, combining for a roughly 47-point boost for the Dow. Other components contributing significantly to the gain include Visa (V), IBM (IBM), and Salesforce (CRM). A $1 move in any one of the 30 components of the Dow results in a 6.59-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2022.

	

(END) Dow Jones Newswires

November 14, 2022 14:40 ET (19:40 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.